Tracheobronchial (TB) narrowing in infants, due to either congenital or acquired aetiologies, can compromise breathing and result in significant and even life-threatening respiratory distress. Traditionally, in patients who fail medical management, surgical interventions such as tracheostomy, tracheoplasty, bronchoplasty, thoracotomy and extracorporeal life support may be needed. These alternatives are all quite invasive, expensive and associated with further adverse effects. TB stent placement can rapidly provide durable and stable intraluminal support to maintain sufficient patency and improve quality of life.1–5 Since 1990, metallic stent placement, which has become an option in children, provides several advantages in select patients as a less-invasive management approach. Balloon-expandable metallic stents (BEMSs) have the unique benefit of further expansion for still-growing TB lumens in paediatric patients. Although therapeutic flexible bronchoscopy (TFB) with different instruments has been reported for decades, information on their application in BEMS placement and associated management of small infants remains scarce. Most studies on paediatric stent placement to date have involved rigid endoscopy (RE), endotracheal tube (ET) and/or mechanical ventilator support while the patients required transport to the operating room with complicated life-supporting equipment. Furthermore, these studies enroled small number of cases and provided insufficient details on metallic stent placement, maintenance management, retrieval and long-term outcomes.6–10
At our institution, a referral centre for complicated and difficult paediatric airway diseases, many children were referred from both local and overseas tertiary centres for failed weaning following prolonged ET or positive-pressure ventilation (PPV) support. The standard management at our institution includes TFB with a noninvasive ventilation (NIV) technique, which we define as nasopharyngeal oxygen with intermittent nose closure and abdominal compression.11,12 This technique provides ventilation without using ventilation bags, masks, artificial airways or ventilators. Since 1997, we have gradually developed and employed this TFB-NIV for many airway procedures including TB BEMS implantation and subsequent management. This technique for BEMS placement and long-term outcomes in paediatric patients were reported recently.13 However, its implementation and outcomes in small infants have not been elucidated.
The purpose of this study was to report our experience using TFB-NIV in the management of TB BEMS including placement, maintenance, long-term outcomes and retrieval in small infants.
This retrospective study included infants who fulfilled the following criteria: (1) a maximum body weight (BW) of 5.0 kg at the time of BEMS placement, (2) placement of BEMS between January 2005 and December 2017 and (3) available medical records and associated BEMS videos for review.
The following data were collected from the review of medical charts and associated videos: case number, age, sex, BW at the time of placement, symptoms, indication, major underlying aetiology, location of the implant, stent diameter at the placement and the final balloon dilatation plasty (BDP), surveillance management, retrieval, complications, cause of mortality, the last FB before the end of study and long-term outcomes of these implanted stents and patients. The study was approved by the institutional review board of Taipei Veterans General Hospital (TVGH IRB No.: 2018-04-008AC).
All BEMS-associated procedures were performed in the endoscopy room of the paediatric intensive care unit with all instruments necessary for monitoring and resuscitation. All infants were in supine position, with the bronchoscopist standing by the infant’s head. Procedural sedation was titrated with intravenous midazolam (0.3-0.5 mg/kg), ketamine (1.0-2.0 mg/kg) and atropine sulfate 0.01 to 0.02 mg/kg (maximum 0.4 mg). Vital signs including heart rate, respiration and oxygen saturation by pulse oximetry (SpO2) were monitored continuously, and blood pressure was recorded intermittently using noninvasive methods from the initiation of the procedure until 4 hours after the procedure. Following the conclusion of the procedure, the infants were admitted to the paediatric intensive care unit for continuous care.
In the current cohorts, an FB with a short working length (25-36 cm) and an outer diameter of 3.2 to 5.0 mm (Olympus; HYF-V, ENF-VQ, ENF-V2 and ENF-VT2), with or without an inner channel, was introduced via the nostril of the infant. A brief summary of the NIV technique, reported previously,11,12 is as follows. A basic continuous, heated and humidified pure oxygen flow (1.0 L/kg/min, maximum 5.0 L/min) was supplied via a nasopharyngeal catheter to fill the upper airway cavity. An optional manoeuvre of assisted inspiration and expiration was performed as follows: the infant’s mouth was firmly closed with scopist’s index finger of right hand. Inspiration was assisted by nose closure (with thumb and mid-finger) accompanied with application of pressure to the cricoid. Expiration was assisted by the release of nose and cricoid manoeuvre with simultaneous abdominal compression. This assisted ventilation was optionally performed at a rate of 10 to 20 cycles per minute based on the patient’s monitoring. The scopist executed both the FB and nose closure (release) manoeuvre, whereas an assistant delivered the abdominal compression (release). No artificial ventilation bags, masks, airway tubes or mechanical ventilators were used during the entire FB procedure.
Indications for stent placement were severe TB malacia or narrowing with frequent life-threatening episodes and prolonged ET or PPV support, which could not be weaned. Stent placement was the last resort before more invasive surgical approaches.1,4,5,14,15 After stent implantation, subsequent TFB interventions were individually scheduled in periods of 2 to 6 months to inspect and manage associated complications. These TFB interventions included forceps debridement and laser ablation to remove granulation, BDP to debulk granuloma as well as to expand the stent to fit the growing TB lumen. All of these interventions were aimed to maintain the lumen and the patency of these implanted stents. During surveillance of management, the stent lumens could be gradually expanded and measured simultaneously using BDP. For each implanted stent, the final diameter was the balloon diameter used for the latest BDP. Surveillance periods varied based on the stent outcomes and started from the time of stent placement until 6 months after stent retrieval, death or the end of the study period.
Data were presented as means ± SD, medians with ranges and/or binomial percentages, as appropriate. Stent diameters were compared using paired samples t test, and a p value <0.05 was considered to indicate statistical significance.
The clinical characteristics of the study cohort are summarised in Table 1. There were 24 consecutive infants with 41 implanted stents during the 13-year period of this retrospective study. In all cases (100%), BEMS was successfully placed in the assigned location. At the time of stent placement, the median BW was 4.0 (range, 2.3-5.0) kg, and the median age was 4.8 (range, 0.3-10.2) months.
The most common underlying aetiology of TB narrowing requiring stent placement was cardiovascular disease in 11 (45.8%) infants, followed by iatrogenic malacia in 6 (25.0%) infants with prolonged use of ET and PPV, tracheoesophageal fistula in 4 (16.7%) infants with severe tracheomalacia and idiopathic aetiology in 3 (12.5%) infants. After the restoration of the TB lumen with BEMS, dramatic respiratory improvement was achieved immediately with rapid weaning from respiratory support in all infants (100%). None of the infants underwent further surgical intervention for TB lumen problems.
The locations of the implanted stents are shown in the Fig. 1. Lower trachea was the leading location in 18 stents (43.9%), followed by the left main bronchus in 10 stents (24.4%). Eight carinal stents (19.5%) were placed using only one long-length (30-40 mm) stent, which was placed distally from one main bronchus, passed through the carina and ended in the lower trachea. The carinal stents were utilised to correct malacia in the pericarinal region. Their lower tracheal and bronchial portions were expanded separately by BDP using different-sized balloons to fit their luminal dimensions.
The outcomes of the infants and the stents are summarised in Table 2. At the end of the follow-up period, seven infants (29.2%) with 13 stents (31.7%) were dead due to the following causes: cardiopulmonary failure in four infants with seven stents, negative attitude of the parents in two infants with cerebral palsy with four stents and pulmonary bleeding in one infant with two stents. There was no apparent stent-related mortality. Seven stents (17.1%) in five infants (20.8%) were retrieved as they were no longer needed in the implanted lumens which had been judged well developed. Twenty-one stents (51.2%) remained in 12 infants (50%) at the end of the follow-up.
The mean surveillance period for all implanted stents was 39.9 ± 36.9 (range, 27.6, 1.4-144.8) months. The mean surveillance periods were 11.7, 52.9 and 52.9 months for the infants who expired, for those whose stents were removed and for those who retained the stents until the end of the study, respectively.
The main stent-associated problems included the following: obstructive granulation formation that caused lumen narrowing, stent distortion and/or loosening from the mucosal wall. All these could be successfully managed with the technique of TFB-NIV. All stent-associated infections or pneumonia could also be controlled appropriately.
At the time of placement, the diameters of 28 tracheal stents (including the tracheal portions of the eight carinal stents) and 21 bronchial stents (including the bronchial portions of the eight carinal stents) were 7.5 ± 1.1 (4-10) and 5.4 ± 0.9 (4-8) mm, respectively. The diameters of the remaining 14 tracheal (7 carinal) and 13 bronchial (7 carinal) stents were 9.6 ± 2.0 (8-14) and 7.2 ± 1.4 (4-10) mm, respectively, suggesting that the implanted BEMSs could be gradually and significantly expanded (p < 0.01).
To the best of our knowledge, this study with the largest cohort of small infants is the first to investigate management and associated long-term outcomes of BEMS implantation using the novel TFB-NIV technique. Several studies that reported TB BEMS in children either included small number of cases 4,5,8,14–17 or in older age-groups.1,4,5,14–17 Their difficulties may bound by small-calibre airways, inappropriate respiratory support and susceptibility to hypoxia during the applications of traditional modalities including RE, ET intubation or while in transportation. Procedural sedation, intra-TB instrumentation and manipulation may further deteriorate the already present cardiopulmonary compromise. However, as previous reports11–13,18–24 in using the TFB-NIV technique, these BEMS-associated procedures can be managed in a safe, simple and effective manner.
All of the infants, included in the current study, had depended on ET or PPV before the stent placement. This NIV, nasopharyngeal oxygen with intermittent nose closure and abdominal compression, using pure oxygen flow and PPV was able to replace the original respiratory support without the constraints of a face mask or other invasive artificial airways such as laryngeal mask airway, ET and ventilator. Nasopharyngeal oxygen insufflation is simple and has already been widely used in clinical practise,25–27 with the advantages of easy accessibility, improved comfort, less oxygen flow and less invasiveness. Nose closure and abdominal compression can assist PPV and expiration. Additionally, abdominal compression can also contribute to circulation, which was proven to be effective in cardiopulmonary support and resuscitation in both animals and adult humans.28–30 This NIV technique has been already demonstrated to be a safe, simple and effective respiratory support and rescue approach during various paediatric FB procedures.11–13,18–24 More advancement, during the TFB-NIV, the bronchoscopists may also have option to control the pressure intensity of the PPV and to dynamically adjusting to facilitate diagnosis as well as treatment.
After BEMS placement, regular medical management such as daily saline and steroids nebulisation with antigastroesophageal reflux regimens are routinely recommended. Scheduled once every 2 to 6 months, clinical and FB assessment of the approachable airway was performed with immediate and appropriate TFB, if indicated. The TFB-NIV technique used for the surveillance and management of BEMS-associated problems such as granulation formation, repair, expansion and retrieval31–36 were enough before they worsened significantly.
The mesh structure of the BEMS, compared with other silicon or membrane stents, aids in retaining the mucociliary function and allows airflow if the stent is placed over the branches. BDP indeed has served several functions in the current study. First, BDP was used to enlarge the stent openings over the bronchial orifices appropriately. Second, the luminal diameter of the BEMS could be further expanded to match the growing airways. Third, distorted stent structures could be repaired or remodelled without replacing with a new stent. Fourth, the stent-associated granulomas could be compressed or debulked simultaneously. No significant luminal obstruction was experienced in the carina or the regions of bifurcation after BDP in the current study. Finally, BDP could also be used to destroy an implanted stent to become a foreign body before its retrieval.
The indications for stent retrieval included nonfunction, destruction beyond repair, associated serious complications, stent placement of more than 2 years and apparently visible stent portion floating over mucosa by FB. In the current study cohort, seven stents, including five tracheal, one carinal and one bronchial stent, were successfully retrieved using RE with forceps. Before retrieval, the preparatory work included the insertion of a guidewire in the gap between the floated stent and the mucosa, followed by balloon inflation (BDP) to destroy and separate the stent from the mucosa for the subsequent retrieval as fragments or whole stent. The residual portions of stent were left on site after the appropriate repair with BDP.
The current study has several limitations. First, this was a retrospective study at a single institution and there was no control group for comparison because the TFB-NIV method employed in conjunction with the BEMS has been performed effectively at our centre for near 20 years. Nonetheless, future, larger cohorts and multicentre studies are necessary for further elucidation of this modality.
In conclusion, BEMS can be an effective and conclusive therapeutic alternative to more invasive surgical interventions for TB malacia and narrowing. TFB-NIV is a safe, convenient and effective technique for BEMS placement and subsequent management in small infants. This approach also allows for successful retrieval of the implanted BEMS by RE once indicated.
This study was financially supported by Taipei Veterans General Hospital (V107C-179).
We thank our study nurses Hsiu-Chun Tsai and Kai-Ting Wen for data collections and analysis.
1. Filler RM, Forte V, Chait P. Tracheobronchial stenting for the treatment of airway obstruction.J Pediatr Surg199833304–11
2. Fayon M, Donato L, de Blic J, Labbé A, Becmeur F, Mely L, et al. French experience of silicone tracheobronchial stenting in children.Pediatr Pulmonol20053921–7
3. Nicolai T, Huber RM, Reiter K, Merkenschlager A, Hautmann H, Mantel K. Metal airway stent implantation in children: follow-up of seven children.Pediatr Pulmonol200131289–96
4. Furman RH, Backer CL, Dunham ME, Donaldson J, Mavroudis C, Holinger LD. The use of balloon expandable metallic stents in the treatment of pediatric tracheomalacia and bronchomalacia.Arch Otolaryngol Head Neck Surg1999125203–7
5. Antón-Pacheco JL, Cabezalí D, Tejedor R, López M, Luna C, Comas JV, et al. The role of airway stenting in pediatric tracheobronchial obstruction.Eur J Cardiothorac Surg2008331069–75
6. Jacobs JP, Quintessenza JA, Botero LM, van Gelder HM, Giroud JM, Elliott MJ, et al. The role of airway stents in the management of pediatric tracheal, carinal, and bronchial disease.Eur J Cardiothorac Surg200018505–12
7. Santoro G, Picardo S, Testa G, Formigari R, Marianeschi S, Catena G, et al. Balloon-expandable metallic stents in the management of tracheomalacia in neonates.J Thorac Cardiovasc Surg19951101145–8
8. Maeda K, Ono S, Tazuke Y, Baba K. Long-term outcomes of congenital tracheal stenosis treated by metallic airway stenting.J Pediatr Surg201348293–6
9. Wells WJ, Hussain NS, Wood JC. Stenting of the main stem bronchus in children: a word of caution.Ann Thorac Surg2004771420–2
10. Kumar P, Bush AP, Ladas GP, Goldstraw P. Tracheobronchial obstruction in children: experience with endoscopic airway stenting.Ann Thorac Surg2003751579–86
11. Soong WJ, Jeng MJ, Lee YS, Tsao PC, Soong YH. Nasopharyngeal oxygen with intermittent nose-close and abdomen-compression: a novel resuscitation technique in a piglet model.Pediatr Pulmonol201348288–94
12. Soong WJ, Jeng MJ, Lee YS, Tsao PC, Harloff M, Soong YH. A novel technique of non-invasive ventilation: pharyngeal oxygen with nose-closure and abdominal-compression--Aid for pediatric flexible bronchoscopy
13. Soong WJ, Tsao PC, Lee YS, Yang CF. Flexible endoscopy for pediatric tracheobronchial metallic stent placement, maintenance and long-term outcomes.PLoS One201813e0192557
14. Leung L, Chung PH, Wong KK, Tam PK. Management of tracheobronchial obstruction in infants using metallic stents: long-term outcome.Pediatr Surg Int201531249–54
15. Xu X, Li D, Zhao S, Liu X, Feng Z, Ding H. Treatment of congenital tracheal stenosis by balloon-expandable metallic stents in paediatric intensive care unit.Interact Cardiovasc Thorac Surg201214548–50
16. Maeda K, Yasufuku M, Yamamoto T. A new approach to the treatment of congenital tracheal stenosis: balloon tracheoplasty and expandable metallic stenting.J Pediatr Surg2001361646–9
17. Filler RM, Forte V, Fraga JC, Matute J. The use of expandable metallic airway stents for tracheobronchial obstruction in children.J Pediatr Surg1995301050–5
18. Soong WJ, Tsao PC, Lee YS, Yang CF. Therapeutic flexible airway endoscopy of small children in a tertiary referral center—11 years’ experience.PLoS One201712e0183078
19. Peng YY, Soong WJ, Lee YS, Tsao PC, Yang CF, Jeng MJ. Flexible bronchoscopy
as a valuable diagnostic and therapeutic tool in pediatric intensive care patients: a report on 5 years of experience.Pediatr Pulmonol2011461031–7
20. Soong WJ, Shiao AS, Jeng MJ, Lee YS, Tsao PC, Yang CF, et al. Comparison between rigid and flexible laser supraglottoplasty in the treatment of severe laryngomalacia in infants.Int J Pediatr Otorhinolaryngol201175824–9
21. Soong WJ, Tsao PC, Lee YS, Yang CF, Liao J, Jeng MJ. Retrieving difficult aspirated pen caps by balloon catheter with short working-length flexible endoscopy and noninvasive ventilation support in intensive care unit.Int J Pediatr Otorhinolaryngol2015791484–9
22. Soong WJ, Lee YS, Soong YH, Tsao PC, Yang CF, Jeng MJ, et al. Tracheal foreign body after laser supraglottoplasty: a hidden but risky complication of an aluminum foil tape-wrapped endotracheal tube.Int J Pediatr Otorhinolaryngol2010741432–4
23. Yang CF, Niu DM, Jeng MJ, Lee YS, Tsao PC, Soong WJ. Late-onset Pompe disease with left-sided bronchomalacia.Respir Care201560e26–9
24. Soong WJ, Lee YS, Tsao PC, Yang CF. Retrieval of tracheobronchial foreign bodies by short flexible endoscopy in children.Int J Pediatr Otorhinolaryngol201795109–13
25. Eastwood GM, O’Connell B, Gardner A, Considine J. Evaluation of nasopharyngeal oxygen, nasal prongs and facemask oxygen therapy devices in adult patients: a randomized crossover trial.Anaesth Intensive Care200836691–4
26. Eastwood GM, Reeves JH, Cowie BS. Nasopharyngeal oxygen in adult intensive care–lower flows and increased comfort.Anaesth Intensive Care200432670–1
27. Soong WJ, Lee YS, Tsao PJ, Yang CF, Jeng MJ. Comparison of oxygenation among different supplemental oxygen methods during flexible bronchoscopy
in infants.J Chin Med Assoc201174556–60
28. Geddes LA, Rundell A, Lottes A, Kemeny A, Otlewski M. A new cardiopulmonary resuscitation method using only rhythmic abdominal compression: a preliminary report.Am J Emerg Med200725786–90
29. Adams CP, Martin GB, Rivers EP, Ward KR, Smithline HA, Rady MY. Hemodynamics of interposed abdominal compression during human cardiopulmonary resuscitation.Acad Emerg Med19941498–502
30. Pargett M, Geddes LA, Otlewski MP, Rundell AE. Rhythmic abdominal compression CPR ventilates without supplemental breaths and provides effective blood circulation.Resuscitation200879460–7
31. Tsai HL, Liu CS, Chen PT, Soong WJ, Chang WK, Chin T. Experience with removing Palmaz stents with a rigid bronchoscope.J Pediatr Surg2004391772–4
32. Ranu H, Madden BP. Endobronchial stenting in the management of large airway pathology.Postgrad Med J200985682–7
33. Alazemi S, Lunn W, Majid A, Berkowitz D, Michaud G, Feller-Kopman D, et al. Outcomes, health-care resources use, and costs of endoscopic removal of metallic airway stents.Chest2010138350–6
34. Nicolai T. Airway stents in children.Pediatr Pulmonol200843330–44
35. Evans PV, Durrant AC, Forte V, Wales P, Chait P, Kim PC. A decade of using intraluminal tracheal/bronchial stents in the management of tracheomalacia and/or bronchomalacia: is it better than aortopexy?J Pediatr Surg200540904–7
36. Lim LH, Cotton RT, Azizkhan RG, Wood RE, Cohen AP, Rutter MJ. Complications of metallic stents in the pediatric airway.Otolaryngol head Neck Surg2004131355–61